WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher U. MisslingPresident and CEO2025-03-24500,000$0.92
$460.00kBuy
Christopher U. MisslingPresident and CEO2025-03-24282,497$9.63
$2.72MSell
Peter Do DonhauserDirector2024-06-142,835$3.64
$10.32kBuy
Steffen ThomasDirector2024-05-155,000$4.52
$22.60kBuy

1 of 1

AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.70%6,552,049$58.64MInstitution
Vanguard Group Inc5.50%4,680,444$41.89MInstitution
State Street Corp2.84%2,411,929$21.59MInstitution
Geode Capital Management LLC2.20%1,874,922$16.78MInstitution
Christopher U. Missling1.73%1,467,713$13.14MInsider
Athanasios Skarpelos1.54%1,306,458$11.69MInsider
Susquehanna International Group LLP1.33%1,134,738$10.16MInstitution
Nwam LLC1.07%913,051$8.17MInstitution
Morgan Stanley1.06%904,159$8.09MInstitution
George Kalkanis1.06%900,000$8.06MInsider

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL34.70%5.13%Net BuyingNet Buying
XNCR70.29%29.71%Net SellingNet Selling
ABCL38.22%44.73%Net BuyingNet Buying
RCKT59.57%40.43%Net SellingNet Selling
DAWN59.43%40.57%Net SellingNet Selling
View Top Biotech Stocks

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 34.70% institutional shareholders, 5.13% Anavex Life Sciences insiders, and 60.17% retail investors. Christopher U. Missling is the largest individual Anavex Life Sciences shareholder, owning 1.47M shares representing 1.73% of the company. Christopher U. Missling's Anavex Life Sciences shares are currently valued at $12.86M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.